Functional, Metabolic, and Morphologic Characteristics of a Novel Rat Model of Type 2 Diabetes-associated Erectile Dysfunction - 06/08/11
, Guiting Lin a, Thomas M. Fandel a, Haiyang Zhang a, Xuefeng Qiu a, Ching-Shwun Lin a, Tom F. Lue a
Reprint requests: Maarten Albersen, M.D., Department of Urology, University Hospitals, Leuven, Leuven, BelgiumRésumé |
Objectives |
To conduct a pilot study to investigate functional, metabolic, and penile morphologic changes in a novel model of lean DM2. Erectile dysfunction (ED) is a frequent sequela in patients with type 2 diabetes mellitus (DM2).
Methods |
Eight rats received a high-fat diet and 2 weeks later, 2 intraperitoneal injections of streptozotocin (STZ, 30 mg/kg). Five age-matched rats served as controls. Insulin challenge tests were performed at 6 and 12 weeks after induction of DM2. At 12 weeks, erectile function was tested by measurement of intracavernous pressure (ICP) increase upon cavernous nerve stimulation. Penile tissue and serum samples were harvested for histology and biochemistry, respectively.
Results |
A lean DM2 model was established as demonstrated by decreased insulin resistance, elevated nonfasting plasma glucose levels, hyperlipidemia, and decreased insulin concentration in the absence of obesity. ICP/mean arterial pressure was significantly decreased in DM2 animals (0.29) compared with controls (0.81). Expression of neuronal nitric oxide synthase and rat endothelial cell antigen-1, and the smooth muscle/collagen ratio were significantly decreased in the penis of DM2 animals.
Conclusions |
We propose an inexpensive nongenetic animal model of lean DM2-associated ED. Microanatomical changes in the erectile tissue that reflect an advanced stage of the disease were observed.
Le texte complet de cet article est disponible en PDF.Plan
| Funding Support: This work was funded by the National Institutes of Health (DK045370). MA is a fellow of the Research Foundation—Flanders (FWO), a scholar of the European Society of Surgical Oncology (ESSO), the Federico Foundation and Belgische Vereniging voor Urologie (BVU), and received an unrestricted research grant from Bayer Healthcare Belgium. |
Vol 78 - N° 2
P. 476.e1-476.e8 - août 2011 Retour au numéro
Article précédent
- Green Tea Extract (Epigallocatechin-3-Gallate) Reduces Efficacy of Radiotherapy on Prostate Cancer Cells
- Francis Thomas, Jeff M.P. Holly, Rajendra Persad, Amit Bahl, Claire M. Perks
- Pathologic Significance and Prognostic Value of Phosphorylated Cortactin Expression in Patients With Sarcomatoid Renal Cell Carcinoma
- Tomohiro Matsuo, Yasuyoshi Miyata, Shin-Ichi Watanabe, Kojiro Ohba, Tomayoshi Hayashi, Shigeru Kanda, Hideki Sakai
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?